Experience with NTBC therapy in hereditary tyrosinaemia type I: an alternative to liver transplantation
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
We present the clinical data of five infants with type I (hepato-renal) tyrosinaemia on NTBC therapy. All presented initially at the local hospital in the 1st year of life with progressive abdominal distension owing to hepato-splenomegaly and with radiological evidence of liver cirrhosis, except for one child who was diagnosed during screening because of an affected sibling. Age at commencement of NTBC therapy ranged from 6 to 30 months. All infants showed remarkable improvement within 2-6 months of starting NTBC treatment, except one who died 2 months after commencement of therapy from uncontrolled liver failure, severe coagulopathy and Streptococcus pneumoniae septicaemia. NTBC treatment along with a phenylalanine- and tyrosine-restricted diet has effectively reversed most clinical manifestations of this disease. To date, none of our patients has developed hepatic carcinoma and NTBC was well tolerated without side-effects. NTBC is costly but life-saving and is an obvious alternative to more hazardous liver transplantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase
LINDSTEDT, S. (1992) · The Lancet · doi:10.1016/0140-6736(92)92685-9 · Cited by 631
Tyrosinaemia type I and NTBC (2‐(2‐nitro‐4‐trifluoromethylbenzoyl)‐1,3‐cyclohexanedione)
Holme, E., & Lindstedt, S. (1998) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005410820201 · Cited by 264
Indications and outcome of liver transplantation in tyrosinaemia type 1
Mohan, N., McKiernan, P., Kelly, D. A., Preece, M. A., Green, A., Buckels, J., & Mayer, A. D. (1999) · European Journal of Pediatrics · doi:10.1007/pl00014321 · Cited by 111
Al-Dhalimy, M., Overturf, K., Finegold, M., & Grompe, M. (2002) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2001.3266 · Cited by 86
Cited by
NTBC treatment in tyrosinaemia type I: Long‐term outcome in French patients
Masurel‐Paulet, A., Poggi‐Bach, J., Rolland, M. ‐., Bernard, O., Guffon, N., Dobbelaere, D., Sarles, J., de Baulny, H. O., & Touati, G. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-0793-1 · Cited by 212
“It is well established that NTBC has greatly improved survival and quality of life (Holme and Lindstedt 1995, 1998, 2000; Joshi and Venugopalan 2004).”
BackgroundExperience of nitisinone for the pharmacological treatment of hereditary tyrosinaemia type 1
Santra, S., & Baumann, U. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.7.1229 · Cited by 68
Clinical practice: NTBC therapy for tyrosinemia type 1: how much is enough?
El-Karaksy, H., Rashed, M., El-Sayed, R., El-Raziky, M., El-Koofy, N., El-Hawary, M., & Al-Dirbashi, O. (2010) · European Journal of Pediatrics · doi:10.1007/s00431-009-1090-1 · Cited by 45
Single dose NTBC‐treatment of hereditary tyrosinemia type I
Schlune, A., Thimm, E., Herebian, D., & Spiekerkoetter, U. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-012-9450-9 · Cited by 33
Monitoring tyrosinaemia type I: Blood spot test for nitisinone (NTBC)
Sander, J., Janzen, N., Terhardt, M., Sander, S., Gökcay, G., Demirkol, M., Ozer, I., Peter, M., & Das, A. M. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.09.027 · Cited by 32
Metadata
- Authors
- Joshi, S. N., & Venugopalan, P.
- Venue
- Annals of Tropical Paediatrics
- Publisher
- Informa UK Limited
- Published
- 2004-09
- Volume
- 24
- Issue
- 3
- Pages
- 259-265
- ISSN
- 0272-4936 (ISSN-L)
- 1465-3281
- OpenAlex
- W2000713786
- Cited by
- 13
- References
- 4
- FWCI
- 0.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Experience with NTBC therapy in hereditary tyrosinaemia type I: an alternative to liver transplantation. https://app.cochat.ai/papers/10.1179/027249304225019000
- The paper
- Joshi, S. N., & Venugopalan, P. (2004). Experience with NTBC therapy in hereditary tyrosinaemia type I: an alternative to liver transplantation. Annals of Tropical Paediatrics. https://doi.org/10.1179/027249304225019000
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.